The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a exciting development. Unlike subcutaneous injections, this technique offers a simpler way to provide GLP-1 https://abeloeyw515827.imblogs.net/90786641/glp-1-patches-a-novel-approach-to-blood-sugar-treatment